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Purpose: Previous studies have indicated that improper use of mitomycin C (MMC) caused cytotoxicity in corneal
endothelial cells. The aim of the present study was to investigate whether MMC induces cellular apoptosis in corneal
endothelial cells and to determine the mechanism by which this may occur.
Methods: Porcine corneal endothelial cells were acquired from primary culture. Cellular damage and caspase pathway
were  estimated  with  a  MTT  (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl  tetrazolium  bromide)  assay.  The  apoptotic
characteristics were detected by means of flow cytometry, the TUNEL (terminal deoxyribonucleotidyl-transferase-(TdT)-
mediated deoxyuridine-5′-triphosphate-digoxigenin (dUTP) nick-end labeling) test, immunofluorescent staining, and
western blotting.
Results: The results indicated that MMC was toxic to corneal endothelial cells in a time-dependent and dose-dependent
manner. Pretreatment with a general caspase inhibitor (Z-VAD-FMK), a caspase-8 inhibitor (Z-IETD-FMK), and a
caspase-9 inhibitor (Z-LEHD-FMK) reversed MMC-induced cellular damage. Following exposure to MMC, a change in
the mitochondrial membrane potential was positively detected by flow cytometric assay with MitoLight dye while cellular
cytochrome c that was released from the mitochondria to the cytoplasm was detected by immunofluorescent staining. A
positive TUNEL test revealed that cellular DNA apoptosis had occurred following exposure to 0.001 and 0.01 mg/ml
MMC for 24 h. Positive annexin V-FITC, and negative propidium iodide (PI) staining indicated that the cellular plasma
membrane underwent apoptosis following 0.001 mg/ml MMC exposure for 24 h. Western blot assay demonstrated down-
regulation of the Bcl-2 protein and upregulation of the p53 and p21 proteins, which were all involved in apoptosis induced
by MMC.
Conclusions: These results indicate that mitomycin-induced cellular apoptosis in corneal endothelial cells may be
mediated through caspase-8, caspase-9, and the mitochondrial regulated pathways as well as through upregulation of p53-
dependent and p21-dependent signal transduction pathways.
Adjuvant use of mitomycin C (MMC) is prevalent in the
treatment of various ocular diseases including pterygium [1],
glaucoma  [2],  and  refractive  surgery  [3]  to  improve  the
success of clinical therapy. MMC is applied by topical drops,
local soaking, or subconjunctival injection during or after
pterygium [4] and glaucoma [5] surgeries to inhibit cellular
proliferation. For laser refractive surgery, MMC is applied
with  local  soaking  to  the  cornea  to  modulate  corneal
keratocyte growth and to decrease the postoperative corneal
opacity  [6].  When  MMC  is  topically  soaked  onto  the
pterygium area, a scleral flap, or the cornea, a certain amount
of MMC may penetrate into the corneal endothelium where it
causes  toxicity  to  corneal  endothelial  cells.  In  clinical
observations, a significant loss of these cells is noted after
trabeculectomy with adjunctive MMC soaking [7]. Evidence
has also presented that a single application of MMC onto the
corneal surface can cause dose-dependent corneal edema and
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endothelial apoptosis in a rabbit model system [8]. Thus,
improper use of MMC as an ocular medication may result in
damage to the cornea and impair the physiologic function of
the corneal endothelium.
It is known that corneal endothelial cells play a crucial
role  in  maintaining  corneal  transparency.  Corneal  clarity
requires a net movement of fluid from the corneal stroma to
the aqueous humor [9], and the efficiency of this flux depends
on the presence of undamaged corneal endothelial cells and
adequate  cellular  density.  Any  factor  that  decreases  cell
density in the endothelium may also reduce the efficiency of
the corneal pump function and therefore affect transparency
[10].
We have previously demonstrated that MMC is toxic to
corneal  endothelial  cells  in  a  time-dependent  and  dose-
dependent manner [11]. Exposure of corneal endothelial cells
to MMC for a certain dose and incubation time may induce
apoptosis.  This  is  a  process  of  natural  cell  death  that  is
characterized  by  an  extreme  heterogeneity  of  signal
transduction  pathways  that  lead  to  DNA  degradation  and
dysfunctions  of  the  plasma  membrane  and  mitochondria,
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1705which are accompanied by a series of degenerative pathways
[12,13]. To evaluate the potential chronic toxicity of MMC,
cultured porcine corneal endothelial cells were used in the
present study to investigate the apoptotic characteristics and
mechanisms involved in corneal damage induced by MMC.
METHODS
Materials: Cell culture materials including trypsin, minimal
essential medium (MEM), glutamine, gentamicin, and fetal
bovine serum were obtained from Gibco (Grand Island, NY).
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium
bromide) was purchased from Sigma Chemical (St. Louis,
MO). The general caspase inhibitor, Z-VAD-FMK; caspase-8
inhibitor, Z-IETD-FMK; caspase-9 inhibitor, Z-LEHD-FMK;
and  a  TUNEL  (terminal  deoxyribonucleotidyl-transferase-
(TdT)-mediated  deoxyuridine-5′-triphosphate-digoxigenin
(dUTP)  nick-end  labeling)  apoptosis  detection  kit  were
purchased  from  Calbiochem  (Bad  Soden,  Germany).  A
MitoLight  mitochondrial  apoptosis  detection  kit  was
purchased from Chemicon International Inc. (Temecula, CA).
Rabbit antibodies to cytochrome c and p21 were purchased
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Alexa
Fluor 488-conjugated goat anti–rabbit antibody; the annexin
V– FITC/propidium iodide double staining kit; and mouse
anti–human antibodies to Bcl-2 and p53 were purchased from
Invitrogen (Carlsbad, CA). Western Blot Chemiluminescence
Reagent  Plus  was  purchased  from  New  England  Nuclear
(PerkinElmer, Boston, MA). Protein assay dye and agents
used  for  electrophoresis  were  purchased  from  Bio-Rad
(Richmond, CA). Horseradish peroxidase-conjugated sheep
anti-mouse IgG and donkey anti–rabbit IgG were obtained
from  Amersham  Pharmacia  (Buckinghamshire,  England).
Mitomycin C (MMC) was purchased from Kyowa (Hakko
Kogyo Co., Tokyo, Japan). All other chemicals were obtained
from Merck (Darmstadt, Germany).
Culture  of  porcine  corneal  endothelial  cells:  Culture  of
porcine corneal endothelial cells was performed as published
previously [11]. Briefly, porcine eyeballs were collected from
a local slaughterhouse. Under sterile conditions, the corneal
endothelial cells were separated using 0.25% trypsin for 30
min. The action of trypsin was stopped by adding minimal
essential medium (MEM) containing 10% fetal bovine serum,
3.8  mM  L-glutamine,  and  50  μg/ml  gentamicin.  After
centrifugation, the cells were resuspended in a culture flask.
The culture was kept in a humidified chamber of 5% CO2 at
37 °C, and the medium was changed every two to three days.
Assay of cell viability with MTT: Cell viability was measured
with MTT dye following previously published procedures
[14]. The MTT assay is based on the production of purple
formazan from a methyl tetrazolium salt by the mitochondrial
enzymes of viable cells. Cultured cells at a concentration of
4,000 cells/well were seeded in 96 well culture plates and
allowed to form a monolayer for 24 h. The cells were then
exposed to 150 μl of serum-free MEM medium containing
various concentrations of MMC for 15 h and 24 h. For analysis
of apoptotic caspase pathways, cells were pre-incubated with
different  caspase  inhibitors  including  a  general  caspase
inhibitor  (Z-VAD-FMK),  a  caspase-8  inhibitor  (Z-IETD-
FMK), and a caspase-9 inhibitor (Z-LEHD-FMK) for 1 h
before adding 0.001 mg/ml MMC. After exposure to the drug
for 24 h, cells were washed twice with phosphate-buffered
saline  (PBS)  and  incubated  with  150  μl  MTT  solution
(0.833 mg/ml in PBS) for 4 h at 37 °C. At the end of the
incubation period, the MTT solution was carefully aspirated,
taking care not to disturb the crystal of purple formazan at the
bottom  of  each  well.  The  formazan  reaction  product  was
dissolved  by  the  addition  of  150  μl  dimethyl  sulfoxide
(DMSO), and the optical density of the fluid in each well was
read at 510 nm in a multi-well spectrophotometer (Titertek
Multiscan,  Flow  Lab,  Scotland,  UK).  Cytotoxicity  was
calculated based on a significant difference in the optical
density between the MMC-treated and control groups.
Immunofluorescent  staining  of  cytochrome  c  protein  in
corneal endothelial cells: Coverslips coated with a confluent
monolayer  of  cells  were  treated  with  MMC  following
previously  published  procedures  [15].  Cells  were  washed
twice  with  PBS  and  rinsed  with  0  °C  acetone  for  20  s.
Following a thorough PBS washing, rabbit anti-cytochrome
c antibody (1:50) was applied to cells in a humidified chamber
at 37 °C for 1 h. Cells were again washed with PBS and then
incubated with Alexa Fluor 488-conjugated goat anti–rabbit
antibody (1:200) for 1 h at room temperature. The stained
samples  were  then  rinsed  and  mounted.  All  slides  were
examined and photographed with a fluorescence microscope
(Leitz Ortholuxix II; Leitz, Wetzlar, Germany).
Flow  cytometry  assay  of  apoptotic  changes  in  plasma
membrane  and  mitochondrial  membrane  potential:
Apoptosis in the plasma membrane was identified by flow
cytometry  with  annexin  V-FITC/propidium  iodide  (PI)
staining.  Mitochondrial  membrane  potential  changes  were
assayed  with  MitoLight  dye.  In  healthy  cells,  this  dye
accumulates  in  the  mitochondria  and  yields  a  red
fluorescence.  In  apoptotic  cells  where  mitochondrial
membrane potential has been depolarized, the dye aggregates
in the cytoplasm and gives off a green fluorescence, allowing
discrimination of apoptotic and non-apoptotic cells. In the
absence or presence of various concentrations of MMC, cells
were incubated with 1 μg/ml annexin V-FITC and PI for 10
min or with 50 μl of pre-diluted MitoLight solution (900 μl of
water, 1 μl of MitoLight dye, and 100 μl of 10X incubation
buffer) for 15 min following the manufacturer’s instructions.
Cells  were  then  analyzed  by  flow  cytometry  (Becton,
Dickinson Inc., Franklin Lakes, NJ) for a cell count of 10000.
DNA  apoptotic  TUNEL  staining:  Immunohistochemical
evidence  for  DNA  strand  breaks  was  obtained  using  the
TUNEL assay. The cells were plated on coverslips for at least
24  h  for  attachment  and  then  incubated  with  various
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the cells were washed twice with TBS (20 mM Tris-HCl,
140 mM NaCl, pH 7.6). According to the manufacturer’s
instruction, the monolayer of cells was fixed for 20 min in 4%
formaldehyde at room temperature and then washed three
times in TBS. Cell membrane permeability was increased by
treating the samples with 20 μg/ml proteinase K solution at
room temperature for 5 min. Endogenous peroxidase activity
was quenched by immersing the specimens in 2% H2O2 at
room temperature for 5 min. The samples were rinsed by
replacing the hydrogen peroxide solution with labeling buffer
and  reaction  mixture  solution.  The  specimens  were  then
placed in a humidified incubator for 1 h at 37 °C. The labeling
reaction was stopped by immersion in stop buffer at room
temperature  for  5  min.  The  specimens  were  subsequently
washed  in  TBS.  Then,  100  μl  of  streptavidin-horseradish
peroxidase  was  applied  to  the  cells  for  20  min  at  room
temperature. After washing with TBS, the specimens were
immersed  in  diaminobenzidine  (DAB)  solution  at  room
temperature for 5–10 min until a satisfactory color reaction
was achieved. This assay was validated with the use of control
slides,  which  had  been  ascertained  to  contain  apoptotic
(positive control) and non-apoptotic (negative control) cells.
Western blot assay of proteins involved in apoptosis: Bcl-2,
p53,  and  p21  proteins  were  detected  by  sodium  dodecyl
sulfate  (SDS)–PAGE  following  a  previously  published
procedure [15]. Briefly, cells were treated with MMC and
washed  with  10  ml  of  buffer  A  (20  mM  of  N-2-
hydroxyethyl-1-piperazine-N'-2-ethanesulfonic  acid
[HEPES], 1 mM of ethylene diamine tetraacetic acid [EDTA],
2 μg/ml aprotinin, 2 μg/ml leupeptin, and 1 μg/ml pepstatin
A, pH 7.4). Cells were then scraped into the ice-cold buffer A
and immediately homogenized. Protein concentrations were
determined with Bio-Rad protein assay dye. Protein (10 μg)
from each sample was added to the SDS-PAGE sample buffer
and heated in a boiling water bath for 5 min. An aliquot was
then subjected to 10% SDS–PAGE. The proteins separated by
SDS–PAGE were transferred in a Bio-Rad Trans-Blot cell
onto nitrocellulose membranes. Transfer was performed at
100 V for 2 h in a buffer containing 25 mM Tris-HCl, 190 mM
glycine,  0.01%  SDS,  and  20%  methanol.  The  blots  were
blocked at room temperature for 1 h with buffer solution
(20 mM Tris-HCI, 137 mM NaCl, pH 7.6) containing 5%
nonfat  milk  and  0.1%  Tween-20.  Incubation  was  then
performed for 1 h at 37 °C with monoclonal anti-Bcl-2 (1:50),
anti-p53 (1:500), or rabbit anti-p21 (1:250) antibodies. The
nitrocellulose membrane was washed three times with the
same buffer used during the blocking phase and incubated
with  horseradish  peroxidase-conjugated  sheep  anti-mouse
IgG  (1:2,000)  or  donkey  anti–rabbit  (1:10,000)  as  the
secondary  antibody  at  room  temperature  for  1  h.  After
washing,  immunocomplexes  were  visualized  by  adding
Western  Blot  Chemiluminescence  Reagent  Plus.  The
molecular size of the immunoreactive bands was determined
by comparing them with a set of molecular weight marker
proteins (Bio-Rad). Relative band intensity was then analyzed
using  the  LabWorks  software  4.6  from  UVP  Bioimaging
systems (Upland, CA).
Statistical analysis: Data were analyzed by one way ANOVA
followed by Dunnett’s post hoc analysis. The values were
expressed as mean±standard deviation (SD). All data were
significantly different at p<0.05.
RESULTS
Effects of mitomycin C on cell viability and apoptotic caspase
pathways:  The  MTT  assay  is  used  as  a  marker  for  cell
viability. In the present study, MMC produced toxic effects
on corneal endothelial cells. After incubation with MMC for
15 h and 24 h, cell viability was significantly decreased in a
time-dependent and dose-dependent manner at concentrations
ranging from 0.1, 0.01, and 0.001 mg/ml (Figure 1A). To
investigate the role of caspase in MMC-induced apoptosis,
cells were pretreated with various caspase inhibitors for 1 h
then  incubated  with  0.001  mg/ml  MMC  for  24  h.  After
application of caspase inhibitors, the cellular MTT values
were significantly increased in comparison with the MMC
only group. Figure 1B-D show that MTT values of cells were
significantly significantly reduced when comparing the MMC
only groups and the control groups. The addition of caspase-8
inhibitor, general caspase inhibitor, and caspase-9 inhibitors
(Z-IETD-FMK, Z-VAD-FMK, and Z-LEHD-FMK) at 10-5
and 10-6 M reversed the MMC-induced cellular damage.
Assay  of  mitochondrial  membrane  potential  change  after
mitomycin  C  exposure:  Disruption  of  the  mitochondrial
transmembrane potential is one of the earliest intracellular
changes induced by apoptosis. Following exposure to 0.00001
and  0.0001  mg/ml  MMC  for  24  h,  the  fluorescence  of
MitoLight  dye  in  cells  was  obviously  changed  from  the
mitochondria to the cytoplasm as detected by the shift of the
relative  fluorescence  intensity.  Control  cells  showed  red
fluorescence, indicating a normal mitochondrial membrane
potential, while cells treated with 0.00001, 0.0001 and 0.001
mg/ml  MMC  showed  green  fluorescence  (Figure  2).  The
percentage of MitoLight accumulated in the mitochondria was
decreased from 100%±3% of the control (red color) to 47%
±4%  at  0.00001  mg/ml  (green  color)  and  27%±4%  at
0.0001 mg/ml (black color). Exposure to 0.001 mg/ml MMC
destroyed the mitochondrial membrane potential as shown by
the blue color.
Cytochrome c released from the mitochondria into the
cytoplasm is characteristic of cellular apoptosis. In control
cells, the cytochrome c protein was found in the mitochondrial
membrane (Figure 3A). After exposure to 0.001 and 0.01 mg/
ml MMC for 24 h, typical apoptotic cells were recognized that
were shrunken in shape and had lost contact with neighboring
cells. Exposure to 0.001 mg/ml MMC caused the cytochrome
c to slightly disperse in the cytoplasm (Figure 3B). Apoptotic
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1707changes throughout the cytosol were clearly visible following
exposure to 0.01 mg/ml MMC for 24 h (Figure 3C).
Apoptotic TUNEL staining: Characterization of apoptosis was
performed by TUNEL staining. In comparison to the negative
staining observed in control cells (Figure 4A), cells exposed
to 0.001 mg/ml MMC for 24 h were seen to contain cellular
chromatin  condensed  and  marginalized  at  the  nuclear
membrane (Figure 4B). After exposure to 0.01 mg/ml MMC
for 15 h, almost all cells were seriously damaged and showed
typical apoptotic bodies, which contained cytosol, condensed
chromatin, and organelles (Figure 4C).
Annexin V-FITC/propidium iodide staining in cellular plasma
membrane with flow cytometry: To identify apoptosis of the
plasma  membrane,  annexin  V-FITC/PI  double  staining  in
cells was performed by flow cytometry. In the nonapoptotic,
viable  control  cells,  the  annexin  V-FITC  staining  and  PI
negative staining were located in the bottom left quadrant of
the dots (Figure 5A). After exposure of the cells to 0.001 mg/
ml MMC for 24 h, a significant number of cells showed
annexin  V-FITC  positive  and  PI  negative  staining,  which
increased the dot numbers in the bottom right quadrant from
7%±2% of control cells to 48%±3% (Figure 5B). The cells in
this stage of apoptosis were still viable. Following the increase
Figure 1. Effects of mitomycin C on cell viability and apoptotic
caspase pathways. A: Cell viability was measured under exposure to
various concentrations of mitomycin C at 15 h and 24 h in cultured
porcine corneal endothelial cells. B, C, and D: The mitomycin-
induced apoptotic caspase pathways were identified with different
caspase  inhibitors.  The  cells  were  pretreated  with  a  caspase-8
inhibitor (Z-IETD-FMK; B), a general caspase inhibitor (Z-VAD-
FMK; C), or a caspase-9 inhibitor (Z-LEHD-FMK; D) for 1 h and
then  exposed  to  0.001  mg/ml  mitomycin  C  for  24  h.  Data  are
presented as means±SD from six replicates and three independent
experiments. The asterisk denotes that p<0.05 when comparing the
control group in A with the MMC only treated group in B, C, and
D.
of MMC to 0.01 mg/ml, cells in advanced apoptosis stained
positive with annexin V-FITC and PI (upper right quadrant)
and were significantly augmented from 12%±3% of control
cells to 34%±3% after 15 h (Figure 5C) and 49%±4% after 24
h incubation (Figure 5D). The population of cells progressed
to advanced apoptosis, indicating that the cells were no longer
viable.
Immunoblot analysis of proteins involved in apoptosis: To
investigate  the  effect  of  MMC  on  proteins  involved  in
apoptosis in cultured corneal endothelial cells, we examined
the anti-apoptotic protein, Bcl-2, and two apoptotic proteins,
p53 and p21, through western blot analysis. The results of
three  independent  experiments  demonstrated  that  MMC
significantly  decreased  the  content  of  Bcl-2  protein  and
Figure 2. Flow cytomety assay of mitochondrial membrane potential
changes with MitoLight dye in cultured porcine corneal endothelial
cells under exposure to 0.00001, 0.0001, and 0.001 mg/ml mitomycin
C for 24 h. A: The curves represent fluorescent changes in the
absence  of  mitomycin  C  for  24  h  (control,  red  color)  or  in  the
presence of 0.00001 (green color), 0.0001 (black color) and 0.001
(blue color) mg/ml mitomycin C. B: It is displayed the ratio of red
fluorescence  in  the  mitochondria  and  green  fluorescence  in  the
cytoplasm  at  different  concentrations  of  mitomycin  C  with
histogram. The asterisk denotes that p<0.05 when comparing the red
and green fluorescence with control group. Two other independent
experiments produced similar results.
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1708increased the amount of p53 and p21 proteins in a dose-
dependent manner (Figure 6). Densitometric analysis of Bcl-2
proteins bands showed that the optical density of proteins in
control cells, 0.01 mg/ml MMC-treated cells, and 0.001 mg/
ml MMC-treated cells was displayed as 336±8 (100%±4% of
Figure 3. Immunofluorescent staining of cytochrome c in cultured
corneal endothelial cells. Cells were incubated either in the absence
of mitomycin C for 24 h (control, A) or in the presence of 0.001 mg/
ml (B) and 0.01 mg/ml (C) mitomycin C for 24 h. The intensity of
fluorescence staining with cytochrome c was gradually enhanced
from  the  control  cells  to  the  apoptotic  cells.  Apoptotic  changes
throughout the cytosol were clearly visible following exposure to
0.01 mg/ml mitomycin C for 24 h. The bar in each panel represents
5 μm. Two other independent experiments produced similar results.
the control), 241±7 (64%±4% at 0.01 mg/ml MMC), and
292±9  (86%±5%),  respectively.  In  contrast,  the  optical
Figure 4. Apoptotic DNA characteristics of corneal endothelial cells
visualized with TUNEL staining. Cells were incubated either in the
absence of mitomycin C for 15 h and 24 h (control, A) or in the
presence  of  0.001  mg/ml  MMC  for  24  h  (B)  and  0.01  mg/ml
mitomycin-C for 15 h (C). The typical positive DNA apoptosis was
clearly stained following exposure to mitomycin C. After exposure
of cells to 0.001 mg/ml mitomycin C, cellular chromatin condensed
and marginalized at the nuclear membrane. After exposure to 0.01
mg/ml  mitomycin  C,  cells  were  seriously  damaged  and  formed
typical apoptotic bodies containing cytosol, condensed chromatin,
and organelles. Each bar represents 3 μM. Two other independent
experiments produced similar results.
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1709density for p53 proteins was 168±6 (control), 253±7 (0.01 mg/
ml MMC) and 182±6 (0.001 mg/ml MMC). The protein only
significantly  increased  at  0.01  mg/ml  (139%±4%  of  the
control). In the presence of 0.01 and 0.001 mg/ml MMC for
24 h, optical density of p21 proteins were 111±7 (control),
415±9 (0.01 mg/ml MMC), and 166±6 (0.001 mg/ml MMC),
which corresponded to an increase of 373%±6% for 0.01 mg/
ml and 149%±7% for 0.001 mg/ml over control values.
DISCUSSION
In  the  present  study,  the  mechanism  of  MMC-induced
apoptosis in corneal endothelial cells was investigated using
cultured porcine cells. This work presents the findings that
MMC treatment not only decreases cell viability but also
induces apoptosis. The effects included turnover of membrane
phosphatidylserine, as identified by annexin V-FITC, DNA
degradation, as characterized with TUNEL staining, changes
in membrane potential, as characterized by the release of
cytochrome c from mitochondria, and upregulation of p53 and
p21 proteins, caspase-8 and caspase-9.
Figure  5.  Flow  cytometry  analysis  of  plasma  membranes  with
annexin V-FITC/PI double staining. Cells were incubated either in
the absence of mitomycin C for 15 h and 24 h (control, A) or in the
presence of 0.001 mg/ml of mitomycin C for 24 h (B) and 0.01 mg/
ml mitomycin C for 15 h (C) and 24 h (D). Undamaged cells were
stained with negative annexin V-FITC/PI (bottom left quadrant).
After  incubation  with  0.001  mg/ml  mitomycin  C  for  24  h,  a
significant  number  of  apoptotic  cells  were  stained  with  positive
annexin V-FITC and negative PI (bottom right quadrant). Following
the increasing of mitomycin C to 0.01 mg/ml, advanced apoptotic
cells  stained  by  positive  annexin  V-FITC  and  PI  (upper  right
quadrant) were significantly augmented from 12%±3% of the control
to 34%±3% after 15 h and 49%±4% after 24 h incubation. During
advanced apoptosis stages, the cells were no longer viable. Data are
presented  as  means±SD  from  triplicates  and  three  independent
experiments. Two other independent experiments produced similar
results.
Application of MMC for the treatment of various ocular
diseases has become more and more popular. However, it is
not easy to detect obvious damage to corneal endothelial cells
unless the side effects of MMC are severe enough to interfere
with normal cellular physiologic function. A recent study has
reported that a significant loss of corneal endothelial cells was
observed  after  trabeculectomy  with  adjunctive  MMC  in
glaucoma  patients  [7].  Evidence  has  also  shown  that  the
corneal endothelial cell count in patients was significantly
decreased [16] and that permanent corneal edema was induced
after photorefractive keratectomy by topical use of MMC
[17].  Some  earlier  studies  also  found  that  the  aqueous
concentration of MMC linearly increased with increases in the
drug’s exposure time and concentration [18] and that a dose-
dependent increase in corneal thickness, decrease in corneal
clarity, and increase in corneal endothelial apoptosis occurred
after intraoperative application of MMC in an animal study
[8].
Many side effects of MMC often occur only after a period
of clinical use. For example, dying corneal endothelial cells
displayed cell shrinkage and chromatin condensation three
weeks after photorefractive keratectomy [19], suggesting a
high possibility that cells underwent an apoptosis process
induced by MMC. Previous studies have reported that MMC-
induced apoptosis in rabbit corneal keratocytes is mediated
through the caspase-8 and caspase-9 pathways and the release
of cytochrome c protein from the mitochondria [20,21]. In
other ocular tissues, such as human lens epithelial cells, MMC
Figure 6. Western blot assay of proteins involved in apoptosis in
corneal endothelial cells. Following incubation of cells either in the
absence of mitomycin C for 24 h (labeled as C in the image) or in
the presence of 0.01 mg/ml (labeled as 0.01 in the image) and 0.001
(labeled as 0.001 in the image) mg/ml mitomycin C for 24 h, cells
were subjected to SDS–PAGE electrophoresis and immunoblotting
using antisera against Bcl-2, p53, and p21. Densitometric analysis of
protein bands showed the optical density values of various proteins
with a detailed description in the Results. The respective control
values of three proteins were assumed as 100% response. The optical
density of the Bcl-2 protein decreased to 64%±4% at 0.01 mg/ml and
86%±5% at 0.001 mg/ml in comparison with the control protein
value of 100%±4%. The p53 protein only significantly increased at
0.01 mg/ml to 139%±4% over the control value. The p21 protein
increased to 373%±6% at 0.01 mg/ml and 149%±7% at 0.001 mg/
ml in comparison with the control value. Two other independent
experiments produced similar results.
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1710also induces the upregulation of Bax, p53, and caspase-3
[22],  and  in  human  Tenon's  capsule  fibroblasts,  it  also
increases caspase-3, caspase-9, p53, Fas, FasL, and Bad as
well as inducing the release of cytochrome c and changes in
the mitochondrial membrane potential [23]. However, the
mechanism of apoptosis induction by MMC in any tissue,
including corneal endothelial cells, is poorly understood at
present.
Based  on  the  dose  response  of  MMC  in  corneal
endothelial  cells,  we  found  that  disruption  of  the
mitochondrial transmembrane potential was the first apoptotic
characteristic  detected.  The  mitochondrial  depolarization
occurs without necessarily going into the cell death pathway.
The  down-regulation  of  Bcl-2  levels,  the  anti-apoptotic
protein,  may  accelerate  damage  to  the  mitochondria.  The
mitochondria then releases the pro-apoptotic factors such as
cytochrome c from the inner mitochondrial membrane into the
cytosol, which then activates the caspase-9 cascade. Thus,
mitochondrial depolarization is an early event marker to more
severe apoptotic events.
Our data illustrated that MMC induced cellular DNA
fragmentation and then triggered p53 and p21 expression.
MMC damages DNA by cross-linking bases in the same or
adjacent  strands  of  DNA,  which  eventually  induces  a
powerful stimulus such as p53 for apoptosis [24,25]. Then,
p53 directly activates the expression of a large panel of genes
such as p21, which plays a major role in mediating p53-
dependent cell cycle G1 arrest [26,27].
Utilization of annexin V-FITC to identify apoptosis in the
plasma membrane indicated that early apoptotic cells were
clearly stained by annexin V-FITC after 24 h of incubation in
0.001 mg/ml MMC. Following exposure to 0.01 mg/ml MMC
for 24 h, about 20% of the cells were still stained by PI and
annexin V-FITC. Comparing the apoptotic dose response for
the  mitochondria  and  DNA  with  that  for  the  plasma
membrane, the cellular plasma membrane appears to be the
most resistant to MMC-induced damage.
The  apoptotic  caspases  are  activated  by  two  signal
complexes either in response to the ligation of cell surface
death receptors (called extrinsic apoptosis pathways) or in
response to signals originating from the mitochondria (called
intrinsic apoptosis pathways) [23,28]. Evidence has shown
that treatment with MMC increased the expression of Fas and
FasL, which belong to the death receptor pathway [23]. Once
these receptors are activated, caspase-8 is activated for the
execution  of  apoptosis  [29].  Our  data  indicated  that  both
caspase-8  and  caspase-9  inhibitors  reversed  the  MMC-
induced damage, suggesting that MMC-induced apoptosis in
corneal endothelial cells may occur through both intrinsic
mitochondrial-mediated  and  extrinsic  death  receptor-
mediated  caspase  activation.  However,  the  MMC-induced
extrinsic apoptosis pathway in particular needs to be explored
further in corneal endothelial cells.
In summary, this study has demonstrated that MMC not
only results in cytotoxicity in a dose-dependent and time-
dependent  manner  but  also  induces  apoptosis  in  corneal
endothelial cells through activation of intrinsic mitochondrial
and extrinsic caspase-8 apoptotic pathways. The appearance
of apoptotic characteristics in corneal endothelial cells may
extend the chronic toxicity of MMC to cells. Thus, the use of
MMC may need to be carefully monitored for adverse changes
in corneal endothelial cell viability.
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